Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO95780 and Rituximab in relapsed follicular NHL
NCT00517049Phase 2Completed
- Sponsor
- Genentech
- Start
- Mar 2008
- Primary completion
- Dec 2009
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of Apomab in follicular lymphoma (FL), sponsored by Genentech. Started Mar 2008; status: completed.
02
Drugs
Apomab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00517049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00517049.